Ginseng

Wise ES, Armstrong MS, Watson J, Lockwood DN. Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected]. PLoS Negl Trop Dis. 2012;6(6):e1688.

Kumaresan M, Kumar P. Localized cutaneous leishmaniasis in South India: successful treatment with ketoconazole. Indian J Dermatol Venereol Leprol. 2007;73(5):361-2.

von Stebut E, Udey MC. Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect. 2004;6(12):1102-9.

Zahn S, Kirschsiefen P, Jonuleit H, Steinbrink K, Von Stebut E. Human primary dendritic cell subsets differ in their IL-12 release in response to Leishmania major infection. Exp Dermatol. 2010;19(10):924-6.

Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Matsumoto Y. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008;70(6):589-93.

Singh S, Mukherjee A, Khomutov AR, et al. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion. Antimicrob Agents Chemother. 2007;51(2):528-34.

Tang X, Kim AL, Feith DJ, et al. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J Clin Invest. 2004;113(6):867-75.

Namazi MR. Hypothesis: the potential utility of topical eflornithine against cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol. 2008;74(2):158-9.

Namazi MR. Potential utility of disulfiram against leishmaniasis. Indian J Med Res. 2008;127(2):193-4.

Souza AS, Giudice A, Pereira JM, et al. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis. 2010;10:209.

Pazyar N, Yaghoobi R. A rationale of ginseng as a novel addition to the antihirsutism armamentarium. J Altern Complement Med. 2012;18(3):210-1.

Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med. 2010;5:20.

Pazyar N, Omidian M, Jamshydian N. Ginseng as a potential novel addition to the antikeloid weaponry. Phytother Res. 2012;26(10):1579-80.

Song Z, Moser C, Wu H, et al. Ginseng modulerer immunresponset via påvirkning af cytokinproduktionen--sekundaerpublikation [Ginseng modulates the immune response via its effect on cytokine production--secondary publication]. Ugeskr Laeger. 2005;167(33):3054-6.

Larsen MW, Moser C, Høiby N, Song Z, Kharazmi A. Ginseng modulates the immune response by induction of interleukin-12 production. APMIS. 2004;112(6):369-73.

Lee JY, Shin JW, Chun KS, et al. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis. 2005;26(2):359-67.

Yoo BC, Park GH, Okuda H, et al. Inhibitory effect of arginine- derivatives from ginseng extract and basic amino acids on protein- arginine N-methyltransferase. Amino Acids. 1999;17(4):391-400.

Lee SH, Jung BH, Kim SY, Lee EH, Chung BC. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol Res. 2006;54(1):46-9.

Fan ZH, Isobe K, Kiuchi K, Nakashima I. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med. 1995;23(3-4):279-87.

Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev. 2004;36(1):57-104.

Choi CH, Kang G, Min YD. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med. 2003;69(3):235-40.